Swedish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

guanosine/inflammation

Länken sparas på Urklipp
6 resultat

Isoform specific inhibition for treatment of pain and reduction of anesthetic threshold

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
TECHNICAL FIELD OF THE INVENTION BACKGROUND OF THE INVENTION Nitric oxide (NO), which serves as an intracellular messenger, is implicated in a number of processes in the central nervous system. In the spinal cord, considerable evidence has demonstrated that NO contributes to the development of

Isoform specific inhibition for treatment of pain and reduction of anesthetic threshold

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
TECHNICAL FIELD OF THE FIELD INVENTION BACKGROUND OF THE INVENTION Nitric oxide (NO), which serves as an intracellular messenger, is implicated in a number of processes in the central nervous system. In the spinal cord, considerable evidence has demonstrated that NO contributes to the development of

Isoform specific inhibition for treatment of pain and reduction of anesthetic threshold

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND OF THE INVENTION Nitric oxide (NO), which serves as an intracellular messenger, is implicated in a number of processes in the central nervous system. In the spinal cord, considerable evidence has demonstrated that NO contributes to the development of hyperalgesia in models of acute and

Blocking induction of tetrahydrobioterin to block induction of nitric oxide synthesis

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
TECHNICAL FIELD This invention is directed to a novel method of inhibiting the induction of nitric oxide formation in biological systems by bacterial endotoxins and cytokines. BACKGROUND OF THE INVENTION For several decades nitroglycerin has been administered to humans as a vasodilating agent in the

Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
This invention was made at least in part with Government support under Grants HL46403 from the National Institutes of Health. TECHNICAL FIELD This invention is directed to a novel method of inhibiting the induction of nitric oxide formation in biological systems by bacterial endotoxins and

Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
TECHNICAL FIELD This invention is directed to a novel method of inhibiting the induction of nitric oxide formation in biological systems by bacterial endotoxins and cytokines. BACKGROUND OF THE INVENTION For several decades nitroglycerin has been administered to humans as a vasodilating agent in the
Gå med på vår
facebook-sida

Den mest kompletta databasen med medicinska örter som stöds av vetenskapen

  • Fungerar på 55 språk
  • Växtbaserade botemedel som stöds av vetenskap
  • Örter igenkänning av bild
  • Interaktiv GPS-karta - märka örter på plats (kommer snart)
  • Läs vetenskapliga publikationer relaterade till din sökning
  • Sök efter medicinska örter efter deras effekter
  • Organisera dina intressen och håll dig uppdaterad med nyheterna, kliniska prövningar och patent

Skriv ett symptom eller en sjukdom och läs om örter som kan hjälpa, skriv en ört och se sjukdomar och symtom den används mot.
* All information baseras på publicerad vetenskaplig forskning

Google Play badgeApp Store badge